By
MikeH on
April 16, 2013
When exactly the Animas Vibe integrated insulin pump and continuous glucose monitor (CGM) hits the U.S. market is now up to the FDA.
Almost two years after the Animas Vibe hit the market in Europe, this Monday Johnson & Johnson submitted the pump to the U.S. regulatory agency. The company publicly announced the submission during their first quarter earnings call early this morning.
Our Diabetes Community has been anxiously awaiting this news since October, when…
Read more »
By
AmyT on
December 26, 2012
Well, we all made through another year!
Surprised we got through this one? Especially with that purported Mayan prediction about the world ending on Dec. 21, 2012? Well, we’re still here! Predictions of doom were apparently exaggerated… Perhaps the premonitions were of something “magical” that was supposed to happen, so we were crossing our fingers for a cure being discovered or the FDA approving the best-ever fantasy diabetes device… or somesuch.
But short of that…
Read more »
By
AmyT on
December 14, 2012
Today is a happy day for fans of Insulet’s tubeless insulin pump system! The FDA has finally approved the next-generation OmniPod, which is 34% smaller, 25% lighter, and 16% slimmer — yet still holds same 200 units of insulin.
The new design will also feature a “pink slide insert,” that pushes a piece of pink plastic to be visible through a new, second window in the center of the Pod, to “help users verify that…
Read more »
By
AmyT on
December 5, 2012
Wow! We’re excited to welcome not one, but three senior FDA officers as joint guest posters here at the ‘Mine today. All three of these individuals attended and participated in the recent 2012 DiabetesMine Innovation Summit, which we hosted at Stanford University on Nov. 16.
Dr. Alberto Gutierrez gave an opening talk titled “How Different Constituencies Can Work Together to Improve Technology Tools for Diabetes Care” (slides here); Stayce Beck participated in our “Data and…
Read more »
By
AmyT on
November 28, 2012
To my mind, the DiabetesMine Innovation Summit I’ve hosted the last two years is not a “conference.” Rather, in the true tradition of a “Summit,” it aims to bring key decision-makers and other folks passionate about diabetes care together in one room for some very frank conversations about where we are now, what needs improvement, and how we can get to a better place as quickly as possible.
On that note, the Pharma executives and…
Read more »
